ETFMG Treatments Testing and Advancements ETF (GERM) ETF
GERM - Profile & Info
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Treatments, Testing and Advancements Index. The fund invests at least 80% of its total assets in the component securities of the index. The index tracks the performance of U.S.-listed equity securities or depositary receipts of companies that (i) perform research, development, and commercialization of treatments or vaccines for infectious diseases or (ii) engage in the research, development, manufacturing, and provision of biological tests for patients. The fund is non-diversified.
|Issuer||ETF Managers Group|
|Assets Under Management (AUM)||58.44M|
|Underlying Index||Prime Treatments, Testing and Advancements Index|
|ETF Category||Health & Biotech ETFs|
|Net Asset Value (NAV)||$37.70|
GERM - Top Holdings
GERM - Price/Volume Stats
GERM - Recent Returns
GERM - Stock Chart
GERM - Dividends
|Ex-Dividend Date||Type||Payout Amount||Change|
|Loading, please wait...|
Free Investing Ideas Newsletter!
Join over 70,000 investors who get the latest insights and top rated picks from our free investment newsletter.
Most Popular Articles
- Make or Break Time for Gold Bulls
- Should Investors Worry When An ETF Reverse Splits? (ERY, DRV, TZA, TYP)
- As March Rolls to April, Crude Oil Continues to Rise